Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30 , 2021 TRANSITION REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 000-54478 ENOCHIAN BIOSCIENCES INC . ( Name of registrant in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) 2080 Century Park East Suite 906 Los Angeles , CA ( Address of principal executive offices ) Title of Each Class Common Stock , par value $ 0.0001 per share +1 ( 305 ) 918-1980 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : Securities registered pursuant to Section 12 ( g ) of the Act : Common Stock , $ 0.0001 par value Trading Symbol ENOB Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes > No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes > No 45-2559340 ( I.R.S. Employer Identification No. ) 90067-2012 ( Zip Code ) Name of Each Exchange on Which Registered The Nasdaq Stock Market LLC Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Exchange Act during the last 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No